These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1483493)

  • 21. Peculiarities of Pharmacokinetics and Bioavailability of Some Cardiovascular Drugs under Conditions of Antiorthostatic Hypokinesia.
    Polyakov AV; Svistunov AA; Kondratenko SN; Kovachevich IV; Repenkova LG; Savelyeva MI; Kukes VG
    Bull Exp Biol Med; 2020 Feb; 168(4):465-469. PubMed ID: 32146624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of xamoterol, atenolol and propranolol on breathlessness, fatigue and plasma electrolytes during exercise in healthy volunteers.
    Sørensen EV; Jensen HK; Faergeman O
    Eur J Clin Pharmacol; 1991; 41(1):51-5. PubMed ID: 1685993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of aging on the pharmcokinetics of atenolol, metoprolol and propranolol in the rat.
    Belpaire FM; de Smet F; Vynckier LJ; Vermeulen AM; Rosseel MT; Bogaert MG; Chauvelot-Moachon L
    J Pharmacol Exp Ther; 1990 Jul; 254(1):116-22. PubMed ID: 2366179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of increased plasma non-esterified fatty acid concentrations on endurance performance during beta-adrenoceptor blockade.
    van Baak MA; Mooij JM; Wijnen JA
    Int J Sports Med; 1993 Jan; 14(1):2-8. PubMed ID: 8440540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of beta 1-selective and nonselective beta blockade on blood pressure relative to physical performance in men with systemic hypertension.
    Kaiser P; Hylander B; Eliasson K; Kaijser L
    Am J Cardiol; 1985 Apr; 55(10):79D-84D. PubMed ID: 3993553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetic comparison of propranolol and atenolol in people with primary hypertension].
    Telatyńska-Smieszek B
    Ann Acad Med Stetin; 2002; 48():367-80. PubMed ID: 14601489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
    Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
    Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenolol.
    Vogelpoel H; Welink J; Amidon GL; Junginger HE; Midha KK; Möller H; Olling M; Shah VP; Barends DM
    J Pharm Sci; 2004 Aug; 93(8):1945-56. PubMed ID: 15236445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of propranolol and verapamil on plasma ionized calcium and parathyroid hormone in short-term intense isokinetic leg exercise.
    Joborn H; Bergström R; Rastad J; Wide L; Akerström G; Ljunghall S
    Clin Physiol; 1988 Feb; 8(1):1-7. PubMed ID: 3349754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of endotoxin on the stereoselective pharmacokinetics of oxprenolol, propranolol, and verapamil in the rat.
    Laethem ME; Belpaire FM; Wijnant P; Rosseel MT; Bogaert MG
    Chirality; 1994; 6(5):405-10. PubMed ID: 8068500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiorespiratory alterations consequent to endurance exercise training during chronic beta-adrenergic blockade with atenolol and propranolol.
    Wilmore JH; Ewy GA; Freund BJ; Hartzell AA; Jilka SM; Joyner MJ; Todd CA; Kinzer SM; Pepin EB
    Am J Cardiol; 1985 Apr; 55(10):142D-148D. PubMed ID: 3993546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facilitation of calcium blocking and membrane effects by intrinsic sympathomimetic activity.
    Smith HJ; Halliday SE; Briscoe MG; Snow HM
    Cardiovasc Res; 1984 Jan; 18(1):30-6. PubMed ID: 6141007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Divergent effects of atenolol, practolol and propranolol on the peripheral metabolic changes induced by dynamic exercise in healthy men.
    Laustiola K; Uusitalo A; Koivula T; Sovijärvi A; Seppälä E; Nikkari T; Vapaatalo H
    Eur J Clin Pharmacol; 1983; 25(3):293-7. PubMed ID: 6628516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation.
    Lewis RV; McMurray J; McDevitt DG
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):1-6. PubMed ID: 2468920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of beta-blockade on the drift in O2 consumption during prolonged exercise.
    Kalis JK; Freund BJ; Joyner MJ; Jilka SM; Nittolo J; Wilmore JH
    J Appl Physiol (1985); 1988 Feb; 64(2):753-8. PubMed ID: 3372432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise increases plasma concentrations of (R)- and (S)-propranolol.
    Stoschitzky K; Schumacher M; Stark G; Dimai HP; Stauber R; Stoschitzky P; Krejs GJ; Klein W; Lindner W
    Eur J Clin Pharmacol; 1996; 50(4):339-42. PubMed ID: 8803530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic effects of atenolol and doxazosin in healthy volunteers during prolonged physical exercise.
    Cosenzi A; Sacerdote A; Bocin E; Molino R; Mangiarotti M; Bellini G
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):142-6. PubMed ID: 7723344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic effects of verapamil and propranolol during submaximal endurance exercise in patients with essential hypertension.
    van Baak MA; Böhm RO; Petri J; Rahn KH
    Int J Sports Med; 1987 Aug; 8(4):270-4. PubMed ID: 3667024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of the influence of nifedipine on the pharmacokinetics and pharmacodynamics of propranolol, metoprolol and atenolol.
    Gangji D; Juvent M; Niset G; Wathieu M; Degreve M; Bellens R; Poortmans J; Degre S; Fitzsimons TJ; Herchuelz A
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):29S-35S. PubMed ID: 6146337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.